Works in Breast Cancer Research, 2025, Vol 27, Issue 1


Results: 115
    1
    2
    3

    Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02070-1
    By:
    • Leon-Ferre, Roberto A.;
    • Dimitroff, K.;
    • Yau, C.;
    • Giridhar, K. V.;
    • Mukhtar, R.;
    • Hirst, G.;
    • Hylton, N.;
    • Perlmutter, J.;
    • DeMichele, A;
    • Yee, D;
    • van 't Veer, L;
    • Rugo, H;
    • Symmans, W. F.;
    • Goetz, M. P.;
    • Esserman, L.;
    • Boughey, J. C.
    Publication type:
    Article
    4
    5

    Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02063-0
    By:
    • Ryu, Seungyeon;
    • Kim, Hoe Suk;
    • Lee, Sangeun;
    • Yoon, So-Hyun;
    • Baek, Moonjou;
    • Park, A Young;
    • Lee, Han-Byoel;
    • Kim, Ga Yeon;
    • Park, Kyung Hyeun;
    • Jung, Ji-Jung;
    • Han, Yireh;
    • Lee, Dong Woo;
    • Ku, Bosung;
    • Han, Wonshik
    Publication type:
    Article
    6

    Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02014-9
    By:
    • Chang, Alexander Chih-Chieh;
    • Balic, Marija;
    • Bartholow, Tanner;
    • Bhargava, Rohit;
    • Brown, Daniel D.;
    • Brown, Lauren;
    • Brufsky, Adam;
    • Cao, Ye;
    • Carleton, Neil;
    • Clark, Amanda M.;
    • Cody, Morgan;
    • Ding, Kai;
    • Deible, Christopher;
    • Elangovan, Ashuvinee;
    • Foldi, Julia;
    • Geisler, Daniel;
    • Hodgdon, Christine;
    • Howard, Naomi;
    • Li, Zheqi;
    • Liu, Jie Bin
    Publication type:
    Article
    7
    8
    9

    Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02056-z
    By:
    • Wilhelm, Alexis;
    • Flynn, Charlotte;
    • Hammer, Evelyn;
    • Roessler, Johannes;
    • Haller, Bernhard;
    • Napieralski, Rudolf;
    • Leuthner, Moritz;
    • Tosheska, Sanja;
    • Knoops, Kèvin;
    • Mathew, Anjusha;
    • Ciarimboli, Giuliano;
    • Kranich, Jan;
    • Flaskamp, Lavinia;
    • King, Siobhan;
    • Gevensleben, Heidrun;
    • Emslander, Quirin;
    • Pastucha, Anna;
    • Reisbeck, Mathias;
    • Rief, Lukas;
    • Bronger, Holger
    Publication type:
    Article
    10
    11

    Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02058-x
    By:
    • Van Baelen, Karen;
    • Nguyen, Ha-Linh;
    • Richard, François;
    • Zels, Gitte;
    • Karsten, Maria Margarete;
    • Nader-Marta, Guilherme;
    • Vermeulen, Peter;
    • Dirix, Luc;
    • Dordevic, Adam David;
    • de Azambuja, Evandro;
    • Larsimont, Denis;
    • Maetens, Marion;
    • Biganzoli, Elia;
    • Wildiers, Hans;
    • Smeets, Ann;
    • Nevelsteen, Ines;
    • Neven, Patrick;
    • Floris, Giuseppe;
    • Desmedt, Christine
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

    Published in:
    2025
    By:
    • Nokin, Marie-Julie;
    • Bellier, Justine;
    • Durieux, Florence;
    • Peulen, Olivier;
    • Rademaker, Gilles;
    • Gabriel, Maude;
    • Monseur, Christine;
    • Charloteaux, Benoit;
    • Verbeke, Lieven;
    • van Laere, Steven;
    • Roncarati, Patrick;
    • Herfs, Michael;
    • Lambert, Charles;
    • Scheijen, Jean;
    • Schalkwijk, Casper;
    • Colige, Alain;
    • Caers, Jo;
    • Delvenne, Philippe;
    • Turtoi, Andrei;
    • Castronovo, Vincent
    Publication type:
    Correction Notice
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02048-z
    By:
    • Munhoz, Jaqueline;
    • Newell, Marnie;
    • Goruk, Susan;
    • Ghosh, Sunita;
    • Patel, Dhruvesh;
    • Joy, Anil Abraham;
    • Bigras, Gilbert;
    • Mazurak, Vera;
    • Courneya, Kerry S.;
    • Hemmings, Denise G.;
    • Field, Catherine J.
    Publication type:
    Article
    31
    32
    33
    34
    35

    ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02020-x
    By:
    • Venetis, Konstantinos;
    • Cursano, Giulia;
    • Scafetta, Roberta;
    • Giachetti, Pier Paolo Maria Berton;
    • Concardi, Alberto;
    • De Camilli, Elisa;
    • D'Ercole, Marianna;
    • Mane, Eltjona;
    • Frascarelli, Chiara;
    • Marra, Antonio;
    • Gandini, Sara;
    • Pepe, Francesco;
    • Scagnoli, Simone;
    • Rossi, Silvia Maria;
    • Troiano, Raffaella;
    • Speziale, Elena;
    • De Angelis, Carmine;
    • Troncone, Giancarlo;
    • Malapelle, Umberto;
    • Perrone, Giuseppe
    Publication type:
    Article
    36

    Association between transcriptomic metrics of exogenous antigen presentation and adaptive immunity with locoregional recurrence in localized estrogen receptor negative breast cancer: retrospective review of multi-institutional datasets.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01987-x
    By:
    • Robinson, Timothy J.;
    • Liveringhouse, Casey L.;
    • Wilson, Christopher;
    • Friedman, Sam;
    • Nakashima, Justyn;
    • Mills, Matthew N.;
    • Purcell, Jacob D.;
    • Figura, Nicholas B.;
    • Dongliang, Du;
    • Thapa, Ram;
    • Welsh, Eric;
    • Ahmed, Kamran A.;
    • Grass, G. Daniel;
    • Fridley, Brooke L.;
    • Diaz, Roberto
    Publication type:
    Article
    37
    38

    Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACE.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02030-9
    By:
    • Mavaddat, Nasim;
    • Frost, Debra;
    • Zhao, Emily;
    • Barnes, Daniel R.;
    • Ahmed, Munaza;
    • Barwell, Julian;
    • Brady, Angela F.;
    • Brennan, Paul;
    • Conti, Hector;
    • Cook, Jackie;
    • Copeland, Harriet;
    • Davidson, Rosemarie;
    • Donaldson, Alan;
    • Douglas, Emma;
    • Gallagher, David;
    • Hart, Rachel;
    • Izatt, Louise;
    • Kemp, Zoe;
    • Lalloo, Fiona;
    • Miedzybrodzka, Zosia
    Publication type:
    Article
    39
    40
    41
    42

    AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02015-8
    By:
    • Phi, Lan T. H.;
    • Cheng, Yating;
    • Funakoshi, Yohei;
    • Bertucci, Francois;
    • Finetti, Pascal;
    • Van Laere, Steven J.;
    • Zou, Fang;
    • Long, James P.;
    • Ogata, Suguru;
    • Krishnamurthy, Savitri;
    • Reuben, James M.;
    • Foulks, Jason M.;
    • Warner, Steven L.;
    • Rosenbluth, Jennifer M.;
    • Sood, Anil K.;
    • Tripathy, Debu;
    • Ueno, Naoto T.;
    • Wang, Xiaoping
    Publication type:
    Article
    43
    44
    45

    8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02010-z
    By:
    • Wang, Biyun;
    • Chen, Xiuchun;
    • Li, Hongtao;
    • Sun, Jing;
    • Jia, Xinjian;
    • Sun, Tao;
    • Yao, Yumin;
    • Wang, Jingfen;
    • Li, Jincheng;
    • Wang, Xujuan;
    • Wang, Xiaojia;
    • Geng, Cuizhi;
    • Ren, Yu;
    • Yang, Liuzhong;
    • Jia, Jun;
    • Chen, Yiding;
    • Li, Zhihua;
    • Huang, Yunhui;
    • Li, Baojiang;
    • Ren, Guosheng
    Publication type:
    Article
    46

    Circulating immune cells exhibit distinct traits linked to metastatic burden in breast cancer.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01982-2
    By:
    • Mangiola, S.;
    • Brown, R.;
    • Zhan, C.;
    • Berthelet, J.;
    • Guleria, S.;
    • Liyanage, C.;
    • Ostrouska, S.;
    • Wilcox, J.;
    • Merdas, M.;
    • Fuge-Larsen, P.;
    • Bell, C.;
    • Schröder, J.;
    • Mielke, L. A.;
    • Mariadason, J. M.;
    • Tsao, S. Chang-Hao;
    • Chen, Y.;
    • Yadav, V. K.;
    • Vodala, S.;
    • Anderson, R. L.;
    • Merino, D.
    Publication type:
    Article
    47

    Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02031-8
    By:
    • Brantley, Kristen D.;
    • Jones, Michael E.;
    • Tamimi, Rulla M.;
    • Rosner, Bernard A.;
    • Kraft, Peter;
    • Nichols, Hazel B.;
    • O'Brien, Katie M.;
    • Adami, Hans-Olov;
    • Aizpurua, Amaia;
    • de Gonzalez, Amy Berrington;
    • Blot, William J.;
    • Braaten, Tonje;
    • Chen, Yu;
    • DeHart, Jessica Clague;
    • Dossus, Laure;
    • Elias, Sjoerd;
    • Fortner, Renée T.;
    • Garcia-Closas, Montserrat;
    • Gram, Inger T.;
    • Håkansson, Niclas
    Publication type:
    Article
    48
    49
    50

    Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01996-w
    By:
    • Vethencourt, Andrea;
    • Trinidad, Eva M.;
    • Dorca, Eduard;
    • Petit, Anna;
    • Soler-Monsó, M. Teresa;
    • Ciscar, Marina;
    • Barranco, Alexandra;
    • Pérez-Chacón, Gema;
    • Jimenez, María;
    • Rodríguez, Mario;
    • Gomez-Aleza, Clara;
    • Purqueras, Elvira;
    • Hernández-Jiménez, Enrique;
    • Urruticoechea, Ander;
    • Morilla, Idoia;
    • Subirana, Isaac;
    • García-Tejedor, Amparo;
    • Gil-Gil, Miguel;
    • Pernas, Sonia;
    • Falo, Catalina
    Publication type:
    Article